Jane Street’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $120K | Sell |
17,427
-100,389
| -85% | -$691K | ﹤0.01% | 4932 |
|
|
2025
Q1 | $339K | Buy |
117,816
+72,657
| +161% | +$209K | ﹤0.01% | 4426 |
|
|
2024
Q4 | $212K | Sell |
45,159
-74,734
| -62% | -$351K | ﹤0.01% | 5028 |
|
|
2024
Q3 | $428K | Sell |
119,893
-48,351
| -29% | -$173K | ﹤0.01% | 4484 |
|
|
2024
Q2 | $1.04M | Sell |
168,244
-366,818
| -69% | -$2.27M | ﹤0.01% | 3601 |
|
|
2024
Q1 | $5.05M | Buy |
535,062
+188,212
| +54% | +$1.78M | ﹤0.01% | 1285 |
|
|
2023
Q4 | $2.34M | Buy |
346,850
+308,349
| +801% | +$2.08M | ﹤0.01% | 2313 |
|
|
2023
Q3 | $171K | Sell |
38,501
-27,792
| -42% | -$123K | ﹤0.01% | 4469 |
|
|
2023
Q2 | $219K | Buy |
66,293
+52,039
| +365% | +$172K | ﹤0.01% | 4523 |
|
|
2023
Q1 | $40.6K | Buy |
14,254
+2,567
| +22% | +$7.32K | ﹤0.01% | 5153 |
|
|
2022
Q4 | $85.1K | Buy |
+11,687
| New | +$85.1K | ﹤0.01% | 4754 |
|
|
2022
Q3 | – | Sell |
-37,930
| Closed | -$186K | – | 5945 |
|
|
2022
Q2 | $186K | Buy |
37,930
+22,972
| +154% | +$113K | ﹤0.01% | 4489 |
|
|
2022
Q1 | $354K | Sell |
14,958
-16,281
| -52% | -$385K | ﹤0.01% | 4130 |
|
|
2021
Q4 | $552K | Sell |
31,239
-18,703
| -37% | -$330K | ﹤0.01% | 3352 |
|
|
2021
Q3 | $1.41M | Buy |
+49,942
| New | +$1.41M | ﹤0.01% | 2263 |
|